Back
ZyVersa Therapeutics Stock Price Chart
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Sell
36
ZVSA
ZyVersa Therapeutics
Last Price:
$0.61
Seasonality Move:
-32.28%
7 Day Trial
ALL ACCESS PASS
$
7
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.-
The current trend is relatively stagnant and ZVSA is experiencing slight selling pressure.
ZyVersa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.6 | Buy |
| 20-day SMA: | 0.57 | Buy |
| 50-day SMA: | 0.65 | Sell |
| 200-day SMA: | 1.41 | Sell |
| 8-day EMA: | 0.61 | Buy |
| 20-day EMA: | 0.6 | Buy |
| 50-day EMA: | 0.68 | Sell |
| 200-day EMA: | 12.13 | Sell |
ZyVersa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 54.52 | Buy |
| Chaikin Money Flow: | -25124 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.53 - 0.63) | Buy |
| Bollinger Bands (100): | (0.59 - 1.23) | Sell |
ZyVersa Therapeutics Technical Analysis
| May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ZyVersa Therapeutics Stock
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.65 while ZVSA 8-day simple moving average is 0.60, which is a Buy signal.
-
The stock price of ZVSA is 0.65 while ZyVersa Therapeutics 20-day SMA is 0.57, which makes it a Buy.
-
ZyVersa Therapeutics 50-day simple moving average is 0.65 while ZVSA share price is 0.65, making it a Sell technically.
-
ZVSA stock price is 0.65 and ZyVersa Therapeutics 200-day simple moving average is 1.41, creating a Sell signal.
ZVSA Technical Analysis vs Fundamental Analysis
Sell
36
ZyVersa Therapeutics (ZVSA)
is a Sell
Is ZyVersa Therapeutics a Buy or a Sell?
-
ZyVersa Therapeutics stock is rated a SellThe current ZyVersa Therapeutics [ZVSA] share price is $0.65. The Score for ZVSA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
ZyVersa Therapeutics Stock Info
Market Cap:
3.1M
Price in USD:
0.65
Share Volume:
402.8K
ZyVersa Therapeutics 52-Week Range
52-Week High:
6.30
52-Week Low:
0.47
Sell
36
ZyVersa Therapeutics (ZVSA)
is a Sell
ZyVersa Therapeutics Share Price Forecast
-
What is the ZyVersa Therapeutics stock price today?The ZyVersa Therapeutics stock price is 0.65 USD today.
-
Will ZVSA stock go up or go down?ZyVersa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is ZyVersa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ZyVersa Therapeutics is overvalued.
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.65 while ZVSA 8-day exponential moving average is 0.61, which is a Buy signal.
-
The stock price of ZVSA is 0.65 while ZyVersa Therapeutics 20-day EMA is 0.60, which makes it a Buy.
-
ZyVersa Therapeutics 50-day exponential moving average is 0.68 while ZVSA share price is 0.65, making it a Sell technically.
-
ZVSA stock price is 0.65 and ZyVersa Therapeutics 200-day simple moving average is 12.13, creating a Sell signal.
Fundamental Analysis of ZyVersa Therapeutics
Is ZyVersa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.20 per share, and a decrease next year of $0.00 per share.
Technical Analysis of ZyVersa Therapeutics
Should I short ZyVersa Therapeutics stock?
-
ZVSA Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting ZyVersa Therapeutics is a Sell
-
ZyVersa Therapeutics Relative Strength Index (RSI) is 54.52, which suggest ZyVersa Therapeutics is overbought
-
The Bollinger Bands (25) for ZyVersa Therapeutics is (0.53 - 0.63), which suggest ZyVersa Therapeutics is a Sell
-
The Bollinger Bands (100) for ZyVersa Therapeutics is (0.59 - 1.23), which suggest ZyVersa Therapeutics is a Sell
* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.